These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26488580)
1. Characteristics of Hypovascular versus Hypervascular Well-Differentiated Hepatocellular Carcinoma Smaller Than 2 cm - Focus on Tumor Size, Markers and Imaging Detectability. Sugimoto K; Kim SR; Imoto S; Tohyama M; Kim SK; Matsuoka T; Yano Y; Kudo M; Hayashi Y Dig Dis; 2015 Oct; 33(6):721-7. PubMed ID: 26488580 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. Inoue T; Kudo M; Komuta M; Hayaishi S; Ueda T; Takita M; Kitai S; Hatanaka K; Yada N; Hagiwara S; Chung H; Sakurai T; Ueshima K; Sakamoto M; Maenishi O; Hyodo T; Okada M; Kumano S; Murakami T J Gastroenterol; 2012 Sep; 47(9):1036-47. PubMed ID: 22526270 [TBL] [Abstract][Full Text] [Related]
3. Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases. Matsuda M; Tsuda T; Yoshioka S; Murata S; Tanaka H; Hirooka M; Hiasa Y; Mochizuki T Jpn J Radiol; 2014 Jul; 32(7):405-13. PubMed ID: 24854900 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939 [TBL] [Abstract][Full Text] [Related]
5. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study. Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860 [TBL] [Abstract][Full Text] [Related]
6. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC. Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383 [TBL] [Abstract][Full Text] [Related]
7. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines. Golfieri R; Garzillo G; Ascanio S; Renzulli M Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286 [TBL] [Abstract][Full Text] [Related]
8. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma. Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990 [TBL] [Abstract][Full Text] [Related]
9. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol. Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296 [TBL] [Abstract][Full Text] [Related]
10. Progression of Hepatic Hypovascular Nodules with Hypointensity in the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in Hepatocellular Carcinoma Cases. Saitoh T; Sato S; Yazaki T; Tobita H; Miyake T; Ishihara S; Katsube T; Kitagaki H; Kinoshita Y Intern Med; 2018 Jan; 57(2):165-171. PubMed ID: 29033416 [TBL] [Abstract][Full Text] [Related]
11. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma. Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. Mita K; Kim SR; Kudo M; Imoto S; Nakajima T; Ando K; Fukuda K; Matsuoka T; Maekawa Y; Hayashi Y World J Gastroenterol; 2010 Sep; 16(33):4187-92. PubMed ID: 20806437 [TBL] [Abstract][Full Text] [Related]
13. Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portography. Tanaka Y; Sasaki Y; Katayama K; Hiramatsu N; Ito A; Murata H; Enomoto N; Oshita M; Mochizuki K; Tsujii M; Tsuji S; Kasahara A; Tomoda K; Nakamura H; Hayashi N; Hori M Hepatology; 2000 Apr; 31(4):890-8. PubMed ID: 10733545 [TBL] [Abstract][Full Text] [Related]
14. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma. Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kawai K; Kozaka K J Comput Assist Tomogr; 2011; 35(2):181-6. PubMed ID: 21412087 [TBL] [Abstract][Full Text] [Related]
15. Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI. Kobayashi S; Matsui O; Gabata T; Koda W; Minami T; Ryu Y; Kozaka K; Kitao A Eur J Radiol; 2012 Dec; 81(12):3839-45. PubMed ID: 22884705 [TBL] [Abstract][Full Text] [Related]
16. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis. Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909 [TBL] [Abstract][Full Text] [Related]
17. Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors. Inoue T; Hyodo T; Murakami T; Takayama Y; Nishie A; Higaki A; Korenaga K; Sakamoto A; Osaki Y; Aikata H; Chayama K; Suda T; Takano T; Miyoshi K; Koda M; Numata K; Tanaka H; Iijima H; Ochi H; Hirooka M; Imai Y; Kudo M Dig Dis; 2013; 31(5-6):472-9. PubMed ID: 24281023 [TBL] [Abstract][Full Text] [Related]
18. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma. Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908 [TBL] [Abstract][Full Text] [Related]
19. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation. Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma. Kunishi Y; Numata K; Morimoto M; Okada M; Kaneko T; Maeda S; Tanaka K AJR Am J Roentgenol; 2012 Jan; 198(1):106-14. PubMed ID: 22194485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]